Tag: Drug design

A novel approach to fight a drug resistant fungal pathogen

The initial discovery We are investigating the potential of protein toxins naturally produced by Saccharomyces cerevisiae (Brewer’s/Baker’s yeast) to inhibit the growth of the human pathogen Candida glabrata. These toxin producers are known as killer yeasts to those who study them. We have tested over 15,0000 interactions between our killer yeasts and 130 isolates of …